Sana Biotechnology, Inc. · NASDAQ:SANA
Patel Dhavalkumar Dhirajlal exercised options for 125,000 Sana Biotechnology, Inc. shares (Form 4)
Traded Aug 26 to Aug 27, 2026 · Filed Aug 27, 2026
From Aug 26 to Aug 27, 2026, Patel Dhavalkumar Dhirajlal (EVP, Chief Scientific Officer) exercised options for 125,000 Sana Biotechnology, Inc. shares, leaving 183,352 shares. Filed Aug 27, 2026 (Form 4).
- Options exercised
- 125,000 shares
- Holding after
- 183,352 shares
- Trading plan
- No
- Role
- EVP, Chief Scientific Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 26, 2026 | Common Stock | Option exercise | 125,000 | 224,510 | Direct | |
| Aug 27, 2026 | Common Stock | Shares withheld for tax | 41,158 | US$4.11 | 183,352 | Direct |
Source
Related
- Sana Biotechnology, Inc.
- Patel Dhavalkumar Dhirajlal
- Sana Biotechnology, Inc. shareholders
- Form 4 · Bishop Hans Edgar · Oct 6, 2026
- Schedule 13G/A · Robert Nelsen · Aug 14, 2026
- Form 4 · Bishop Hans Edgar · Jul 7, 2026
- Schedule 13G · Ra Capital Management, L.P. · May 21, 2026
- Form 4 · Bishop Hans Edgar · Apr 8, 2026